Enanta Pharmaceuticals Inc. buy Westpark Capital
Start price
02.09.25
/
50%
€7.60
Target price
02.09.26
€20.51
Performance (%)
17.11%
Price
22.10.25
€8.90
Summary
This prediction is currently active. The prediction currently has a performance of 17.11%. This prediction currently runs until 02.09.26. The prediction end date can be changed by Westpark_Capital at any time. Westpark_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | -6.806% | -6.806% |
| iShares Core DAX® | 0.769% | 2.836% |
| iShares Nasdaq 100 | 2.414% | 3.891% |
| iShares Nikkei 225® | 1.022% | 6.378% |
| iShares S&P 500 | 2.279% | 3.015% |
Comments by Westpark_Capital for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (NASDAQ:ENTA) is now covered by analysts at Westpark Capital. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by Westpark_Capital for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.60
30.09.25
30.09.25
€23.89
30.09.26
30.09.26
-13.21%
22.10.25
22.10.25
